News & Analysis as of

Science, Computers & Technology Art, Entertainment & Sports

Read Science, Computers & Technology updates, news, alerts, and legal analysis from leading lawyers and law firms:
Barnea Jaffa Lande & Co.

US Stablecoin Market Hits Milestone: Regulation and IPO

The stablecoin market has reached a regulatory and business milestone. Two significant actions took place in the United States in recent weeks that signal progress toward the institutionalization of the stablecoin market: the...more

WilmerHale

Congress Set to Bring CLARITY to Digital Asset Market Structure

WilmerHale on

This week’s consideration of H.R. 3633, the Digital Asset Market Clarity Act of 2025 (CLARITY or the Act) in the U.S. House of Representatives is a pivotal moment for the development of US digital asset regulation. ...more

Venable LLP

OIG Reminds Us that Flat Fee Business Arrangements Aren’t Immune from AKS Scrutiny

Venable LLP on

On July 1, 2025, the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services issued Advisory Opinion No. 25-08, concluding that a medical device manufacturer’s proposed payment to access a...more

Latham & Watkins LLP

Digitisation Taskforce Unveils the End of Paper Share Certificates

Latham & Watkins LLP on

Final report recommends the digitisation of UK shareholdings through a fully intermediated system of shareholding, with an interim phase of digitised share registers....more

Venable LLP

Spotlight On: Enbrel® (etanercept) / Erelzi® (etanercept-szzs) / Eticovo® (etanercept-ykro) - July 2025

Venable LLP on

Etanercept Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple...more

Venable LLP

Spotlight On: Actemra® (tocilizumab) / Tofidence™ (tocilizumab-bavi) / Tyenne® (tocilizumab-aazg) / Avtozma® (tocilizumab-anoh) -...

Venable LLP on

Tocilizumab Challenged Claim Types in IPRs: Claims are counted in each IPR, so claims from the same patent challenged in multiple IPRs are counted more than once. Within each IPR, claims are counted only once, whether they...more

McDonnell Boehnen Hulbert & Berghoff LLP

AI News Roundup – Impostor uses AI to imitate U.S. Secretary of State, EU unveils code of practice for AI regulations, AI-powered...

To help you stay on top of the latest news, our AI practice group has compiled a roundup of the developments we are following....more

Jackson Walker

Perceptix v. Meta Platforms – A Headphone Patent Lawsuit Without a Sound Basis

Jackson Walker on

On June 30, 2025, Perceptix filed suit against Meta Platforms for infringement of U.S. Patent 8,498,439, which describes a headphone that turns on when it is worn. The ‘439 Patent is assigned to the Electronics and...more

WilmerHale

AI and EU Merger Control

WilmerHale on

Global investment in AI surged to approximately USD 252 billion in 2024, representing a thirteen-fold increase since 2014. As AI technologies become deeply embedded across key economic sectors such as finance, manufacturing,...more

Lighthouse

AI in Action: Improving TAR in Antitrust Matters

Lighthouse on

Agility, precision, and the ability to stay ahead of the curve are everything in antitrust. In this Q&A, Lighthouse experts Kamika Brown (Client Success Manager, Antitrust) and Fernando Delgado (Senior Director, AI &...more

Venable LLP

Spotlight On: Neulasta® (pegfilgrastim) / Fulphila® (pegfilgrastim-jmdb) / Udenyca® (pegfilgrastim-cbqv) / Ziextenzo®...

Venable LLP on

Pegfilgrastim Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple...more

Paul Hastings LLP

Disparate Impact Lives: Massachusetts Attacks AI in Lending

Paul Hastings LLP on

On July 10, the Massachusetts attorney general announced a $2.5 million settlement with a Delaware-based student loan company to resolve allegations that the company’s lending practices, including the use of artificial...more

Hogan Lovells

AI systems: German DPAs issue guidance on technical and organizational measures

Hogan Lovells on

On 17 June 2025, the German data protection authorities issued substantially revised guidance on technical and organizational measures for the development and operation of AI systems. Aimed at manufacturers and developers,...more

Redgrave LLP

Don’t Rush Past Relevance: Assessing the Discoverability of AI Prompts and Outputs

Redgrave LLP on

Much of the buzz about artificial intelligence (AI) in law has focused on its utility as a discovery tool rather than a potential source of discovery. While AI’s impact on discovery processes, such as reviewing and coding...more

Cooley LLP

Janssen v. Teva: Federal Circuit Upholds Claims to Pharmaceutical Dosing Regimen, Clarifies Presumption of Obviousness for...

Cooley LLP on

On July 8, the US Court of Appeals for the Federal Circuit issued a precedential opinion in Janssen Pharmaceuticals, Inc. et al. v. Teva Pharmaceuticals USA, Inc. affirming the district court’s finding that patent claims to a...more

Hogan Lovells

.You .Talk .Fast!

Hogan Lovells on

Further to the recent launch of the new generic Top Level Domains (gTLDs) .FREE, .HOT and .SPOT in April, Amazon Registry continues the momentum and has announced the upcoming launch of three additional new gTLDs: .YOU, .TALK...more

Hogan Lovells

2025 NMPA Inspection points for clinical trials of medical devices

Hogan Lovells on

Recently, China's National Medical Products Administration (“NMPA”) released a new version of the Inspection Points for Clinical Trials of Medical Devices. This new rule replaces two previous versions published in 2016 and...more

Morgan Lewis

AI in Healthcare: Opportunities, Enforcement Risks and False Claims, and the Need for AI-Specific Compliance

Morgan Lewis on

The risks associated with the growth of AI in the healthcare and life sciences industries, as well as recent federal and state activity and enforcement actions, emphasize the importance of understanding and implementing a...more

Jones Day

EU Commission Signs-off on ESG Related Competitor Collaboration

Jones Day on

The European Commission has issued its first-ever informal approvals of two separate sustainability initiatives among rivals under its revised Informal Guidance Notice and provided guidance on how the companies in question...more

McCarter & English, LLP

Court Sets New Limits on Use of Copyrighted Materials to Train AI Models

The rapid adoption of artificial intelligence (AI) has sparked a pressing legal debate over how copyrighted materials can be used to train generative AI systems, particularly large language models (LLMs), without permission...more

Venable LLP

Spotlight On: Prolia® / Xgeva® (denosumab) / Jubbonti® / Wyost® (denosumab-bbdz) / Ospomyv™ / Xbryk™ (denosumab-dssb) / Stoboclo®...

Venable LLP on

Denosumab Challenged Claim Types in Litigation: Claims are counted in each litigation, so claims from the same patent challenged in multiple litigations are counted more than once. Within each litigation a claim is counted...more

Latham & Watkins LLP

Healthcare Life Sciences Drug Pricing Digest - July 2025

Latham & Watkins LLP on

On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act, his signature policy legislation. Two aspects of this legislation are particularly relevant for drug pricing....more

Cozen O'Connor

Pennsylvania Perspective for Monday, July 14, 2025

Cozen O'Connor on

PA Outlaws Creation of Deepfakes with Malicious Intent - Governor Josh Shapiro (D) signed a bill that will code deepfakes as forgeries, making misleading or malicious digital impersonations illegal. The first offense will be...more

Pagefreezer

If You’ve Ever Asked Your Paralegal to Screenshot a Facebook Profile... Please Read This

Pagefreezer on

Most great attorneys didn’t get where they are alone. While the best attorneys are no doubt talented and deserving, most of them become so because they have a strong support network, hard at work in the background. And...more

Lathrop GPM

Track One Expansion: A Strategic Opportunity Amid USPTO Delays

Lathrop GPM on

Following on our February 2025 alert regarding operational delays at the U.S. Patent and Trademark Office (USPTO), we are pleased to share that the USPTO has expanded the annual cap for Track One Prioritized Examination...more

81,620 Results
 / 
View per page
Page: of 3,265

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide